Literature DB >> 18958874

Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.

Donatella Ciuffreda1, Denis Comte, Matthias Cavassini, Emiliano Giostra, Leo Bühler, Monika Perruchoud, Markus H Heim, Manuel Battegay, Daniel Genné, Beat Mulhaupt, Raffaele Malinverni, Carl Oneta, Enos Bernasconi, Martine Monnat, Andreas Cerny, Christian Chuard, Jan Borovicka, Gilles Mentha, Manuel Pascual, Jean-Jacques Gonvers, Giuseppe Pantaleo, Valérie Dutoit.   

Abstract

HCV infection has a severe course of disease in HIV/HCV co-infection and in liver transplant recipients. However, the mechanisms involved remain unclear. Here, we evaluated functional profiles of HCV-specific T-cell responses in 86 HCV mono-infected patients, 48 HIV/HCV co-infected patients and 42 liver transplant recipients. IFN-gamma and IL-2 production and ability of CD4 and CD8 T cells to proliferate were assessed after stimulation with HCV-derived peptides. We observed that HCV-specific T-cell responses were polyfunctional in HCV mono-infected patients, with presence of proliferating single IL-2-, dual IL-2/IFN-gamma and single IFN-gamma-producing CD4+ and dual IL-2/IFN-gamma and single IFN-gamma-producing CD8+ cells. In contrast, HCV-specific T-cell responses had an effector profile in HIV/HCV co-infected individuals and liver transplant recipients with absence of single IL-2-producing HCV-specific CD4+ and dual IL-2/IFN-gamma-producing CD8+ T cells. In addition, HCV-specific proliferation of CD4+ and CD8+ T cells was severely impaired in HIV/HCV co-infected patients and liver transplant recipients. Importantly, "only effector" T-cell responses were associated with significantly higher HCV viral load and more severe liver fibrosis scores. Therefore, the present results suggest that immune-based mechanisms may contribute to explain the accelerated course of HCV infection in conditions of HIV-1 co-infection and liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18958874     DOI: 10.1002/eji.200838336

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  71 in total

1.  Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses.

Authors:  Raskit Lachmann; Martha Bajwa; Serena Vita; Helen Smith; Elizabeth Cheek; Arne Akbar; Florian Kern
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Functionality of CD4+ and CD8+ T cells from tonsillar tissue.

Authors:  I Sada-Ovalle; A Talayero; L Chavéz-Galán; L Barrera; A Castorena-Maldonado; A Soda-Merhy; L Torre-Bouscoulet
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

3.  Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected].

Authors:  Krystle A Lang Kuhs; Arielle A Ginsberg; Jian Yan; Roger W Wiseman; Amir S Khan; Niranjan Y Sardesai; David H O'Connor; David B Weiner
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

4.  A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose.

Authors:  Melissa A Cobleigh; Linda Buonocore; Susan L Uprichard; John K Rose; Michael D Robek
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 5.  Update on hepatitis C virus-specific immunity.

Authors:  Donatella Ciuffreda; Arthur Y Kim
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

6.  Cytomegalovirus-Responsive CD8+ T Cells Expand After Solid Organ Transplantation in the Absence of CMV Disease.

Authors:  L E Higdon; J Trofe-Clark; S Liu; K B Margulies; M K Sahoo; E Blumberg; B A Pinsky; J S Maltzman
Journal:  Am J Transplant       Date:  2017-03-13       Impact factor: 8.086

7.  COMPASS identifies T-cell subsets correlated with clinical outcomes.

Authors:  Lin Lin; Greg Finak; Kevin Ushey; Chetan Seshadri; Thomas R Hawn; Nicole Frahm; Thomas J Scriba; Hassan Mahomed; Willem Hanekom; Pierre-Alexandre Bart; Giuseppe Pantaleo; Georgia D Tomaras; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Sorachai Nitayaphan; Punnee Pitisuttithum; Nelson L Michael; Jerome H Kim; Merlin L Robb; Robert J O'Connell; Nicos Karasavvas; Peter Gilbert; Stephen C De Rosa; M Juliana McElrath; Raphael Gottardo
Journal:  Nat Biotechnol       Date:  2015-05-25       Impact factor: 54.908

8.  TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

Authors:  Mathilde Allard; Barbara Couturaud; Laura Carretero-Iglesia; Minh Ngoc Duong; Julien Schmidt; Gwennaëlle C Monnot; Pedro Romero; Daniel E Speiser; Michael Hebeisen; Nathalie Rufer
Journal:  JCI Insight       Date:  2017-07-20

9.  A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection.

Authors:  Hongmei Kong; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

10.  Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells.

Authors:  Lance Nesbit; Suzanne M Johnson; Demosthenes Pappagianis; Neil M Ampel
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.